7,590.50

+46.25

+0.61%

52,429.00

+114.00

+0.22%

28,232.75

+397.50

+1.43%

Russell 2000 Futures

2,842.10

+13.20

+0.47%

4.9830

+0.1190

+2.45%

19.46

-0.46

-2.31%

4,069.20

+39.00

+0.97%

73,828.86

-729.73

-0.98%

Crude Oil Dec 26

86.61

+0.57

+0.66%

US Private Equity

10,824.53

-25.62

-0.24%

XETRA - Delayed Quote EUR

Moderna, Inc. (0QF.DE)

228.10 -18.70 (-7.58%)

At close: November 10 at 5:35:57 PM GMT+1

Loading Chart for 0QF.DE

Chart Range Bar

Interval:

In partnership with ChartIQ

Top Stock Picks for Week of November 9, 2026

Top Stock Picks for Week of November 9, 2026

Moderna to Present at Upcoming Conference in November 2026

Moderna to Present at Upcoming Conference in November 2026

What Invesco S&P 500 Equal Weight ETF (RSP) Bought: Moderna Leads on Nov. 6

What Invesco S&P 500 Equal Weight ETF (RSP) Bought: Moderna Leads on Nov. 6

iShares Russell Mid-Cap (IWR) Adds Fox and Marathon Petroleum on Nov. 6

iShares Russell Mid-Cap (IWR) Adds Fox and Marathon Petroleum on Nov. 6

Why is Moderna (MRNA) stock soaring today

Why is Moderna (MRNA) stock soaring today

Why Did U, MRNA, ABNB Stocks Surge To 52-Week Highs Today?

Why Did U, MRNA, ABNB Stocks Surge To 52-Week Highs Today?

Moderna's Q3 Numbers May Have Seemed Impressive, but They Aren't Enough to Make the Stock a Buy

Moderna's Q3 Numbers May Have Seemed Impressive, but They Aren't Enough to Make the Stock a Buy

Is Moderna (MRNA) Priced For Too Much Sales Growth?

Is Moderna (MRNA) Priced For Too Much Sales Growth?

Moderna (MRNA) Stock Fair Value Rises After Intismeran Data And Q3 Beat

Moderna (MRNA) Stock Fair Value Rises After Intismeran Data And Q3 Beat

SanDisk's 64% collapse: another leg down or buying opportunity?

SanDisk's 64% collapse: another leg down or buying opportunity?

Can Moderna's First Cancer Therapy Win FDA Approval in 2027?

Can Moderna's First Cancer Therapy Win FDA Approval in 2027?

Mobilize your Website

View Site in Mobile | Classic

Share by: